Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Working with world class UK universities is essential for growth and prosperity

1 August 2011

There is a lot of discussion about the relationship between world class, research-intensive universities and economic and social prosperity.

It is essential that we fully utilize the intellectual capital and intellectual property from universities in the business sector, third sector and public sector, if we are to propel the UK into a period of sustainable growth. For any entrepreneur or organization not currently working closely with universities here are some ways in which you can work with academia to help start, develop and grow your business.

More...